skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Title: Visual Explanations From Deep 3D Convolutional Neural Networks for Alzheimer’s Disease Classification
We develop three efficient approaches for generating visual explanations from 3D convolutional neural networks (3D- CNNs) for Alzheimer’s disease classification. One approach conducts sensitivity analysis on hierarchical 3D image segmentation, and the other two visualize network activations on a spatial map. Visual checks and a quantitative localization benchmark indicate that all approaches identify important brain parts for Alzheimer’s disease diagnosis. Comparative analysis show that the sensitivity analysis based approach has difficulty handling loosely distributed cerebral cortex, and approaches based on visualization of activations are constrained by the resolution of the convo- lutional layer. The complementarity of these methods improves the understanding of 3D-CNNs in Alzheimer’s disease classification from different perspectives.  more » « less
Award ID(s):
1743050
PAR ID:
10088685
Author(s) / Creator(s):
; ;
Date Published:
Journal Name:
AMIA ... Annual Symposium proceedings
ISSN:
1559-4076
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Neurological disorders generally involve multiple kinds of changes in the functional and structural properties of the brain. In this study, we develop a CNN-based multimodal deep learning pipeline by exploiting both functional and structural neuroimaging features to generate full-brain maps that encode significant differences between patient groups and between modalities in terms of their distinctive contribution towards diagnostic classification of Alzheimer’s disease. Through a repeated cross-validation procedure and robust statistical analysis, we show that our approach can be used to encode highly discriminative and abstract information from full-brain data, while also retaining the ability to identify and categorize significantly contributing voxel-level features based on their salient strength in various diagnostic and modality-related contexts. Our results on an Alzheimer’s disease classification task show that such approaches can be used for creating more elaborately defined biomarkers for brain disorders. 
    more » « less
  2. We introduce a novel framework for the classification of functional data supported on nonlinear, and possibly random, manifold domains. The motivating application is the identification of subjects with Alzheimer’s disease from their cortical surface geometry and associated cortical thickness map. The proposed model is based upon a reformulation of the classification problem as a regularized multivariate functional linear regression model. This allows us to adopt a direct approach to the estimation of the most discriminant direction while controlling for its complexity with appropriate differential regularization. Our approach does not require prior estimation of the covariance structure of the functional predictors, which is computationally prohibitive in our application setting. We provide a theoretical analysis of the out-of-sample prediction error of the proposed model and explore the finite sample performance in a simulation setting. We apply the proposed method to a pooled dataset from the Alzheimer’s Disease Neuroimaging Initiative and the Parkinson’s Progression Markers Initiative. Through this application, we identify discriminant directions that capture both cortical geometric and thickness predictive features of Alzheimer’s disease that are consistent with the existing neuroscience literature. 
    more » « less
  3. Abstract Electrophysiologic disturbances due to neurodegenerative disorders such as Alzheimer’s disease and Lewy Body disease are detectable by scalp EEG and can serve as a functional measure of disease severity. Traditional quantitative methods of EEG analysis often require an a-priori selection of clinically meaningful EEG features and are susceptible to bias, limiting the clinical utility of routine EEGs in the diagnosis and management of neurodegenerative disorders. We present a data-driven tensor decomposition approach to extract the top 6 spectral and spatial features representing commonly known sources of EEG activity during eyes-closed wakefulness. As part of their neurologic evaluation at Mayo Clinic, 11 001 patients underwent 12 176 routine, standard 10–20 scalp EEG studies. From these raw EEGs, we developed an algorithm based on posterior alpha activity and eye movement to automatically select awake-eyes-closed epochs and estimated average spectral power density (SPD) between 1 and 45 Hz for each channel. We then created a three-dimensional (3D) tensor (record × channel × frequency) and applied a canonical polyadic decomposition to extract the top six factors. We further identified an independent cohort of patients meeting consensus criteria for mild cognitive impairment (30) or dementia (39) due to Alzheimer’s disease and dementia with Lewy Bodies (31) and similarly aged cognitively normal controls (36). We evaluated the ability of the six factors in differentiating these subgroups using a Naïve Bayes classification approach and assessed for linear associations between factor loadings and Kokmen short test of mental status scores, fluorodeoxyglucose (FDG) PET uptake ratios and CSF Alzheimer’s Disease biomarker measures. Factors represented biologically meaningful brain activities including posterior alpha rhythm, anterior delta/theta rhythms and centroparietal beta, which correlated with patient age and EEG dysrhythmia grade. These factors were also able to distinguish patients from controls with a moderate to high degree of accuracy (Area Under the Curve (AUC) 0.59–0.91) and Alzheimer’s disease dementia from dementia with Lewy Bodies (AUC 0.61). Furthermore, relevant EEG features correlated with cognitive test performance, PET metabolism and CSF AB42 measures in the Alzheimer’s subgroup. This study demonstrates that data-driven approaches can extract biologically meaningful features from population-level clinical EEGs without artefact rejection or a-priori selection of channels or frequency bands. With continued development, such data-driven methods may improve the clinical utility of EEG in memory care by assisting in early identification of mild cognitive impairment and differentiating between different neurodegenerative causes of cognitive impairment. 
    more » « less
  4. null (Ed.)
    CNNs (Convolutional Neural Networks) are becoming increasingly important for real-time applications, such as image classification in traffic control, visual surveillance, and smart manufacturing. It is challenging, however, to meet timing constraints of image processing tasks using CNNs due to their complexity. Performing dynamic trade-offs between the inference accuracy and time for image data analysis in CNNs is challenging too, since we observe that more complex CNNs that take longer to run even lead to lower accuracy in many cases by evaluating hundreds of CNN models in terms of time and accuracy using two popular data sets, MNIST and CIFAR-10. To address these challenges, we propose a new approach that (1) generates CNN models and analyzes their average inference time and accuracy for image classification, (2) stores a small subset of the CNNs with monotonic time and accuracy relationships offline, and (3) efficiently selects an effective CNN expected to support the highest possible accuracy among the stored CNNs subject to the remaining time to the deadline at run time. In our extensive evaluation, we verify that the CNNs derived by our approach are more flexible and cost-efficient than two baseline approaches. We verify that our approach can effectively build a compact set of CNNs and efficiently support systematic time vs. accuracy trade-offs, if necessary, to meet the user-specified timing and accuracy requirements. Moreover, the overhead of our approach is little/acceptable in terms of latency and memory consumption. 
    more » « less
  5. Abstract Early diagnosis of Alzheimer’s disease plays a pivotal role in patient care and clinical trials. In this study, we have developed a new approach based on 3D deep convolutional neural networks to accurately differentiate mild Alzheimer’s disease dementia from mild cognitive impairment and cognitively normal individuals using structural MRIs. For comparison, we have built a reference model based on the volumes and thickness of previously reported brain regions that are known to be implicated in disease progression. We validate both models on an internal held-out cohort from The Alzheimer's Disease Neuroimaging Initiative (ADNI) and on an external independent cohort from The National Alzheimer's Coordinating Center (NACC). The deep-learning model is accurate, achieved an area-under-the-curve (AUC) of 85.12 when distinguishing between cognitive normal subjects and subjects with either MCI or mild Alzheimer’s dementia. In the more challenging task of detecting MCI, it achieves an AUC of 62.45. It is also significantly faster than the volume/thickness model in which the volumes and thickness need to be extracted beforehand. The model can also be used to forecast progression: subjects with mild cognitive impairment misclassified as having mild Alzheimer’s disease dementia by the model were faster to progress to dementia over time. An analysis of the features learned by the proposed model shows that it relies on a wide range of regions associated with Alzheimer's disease. These findings suggest that deep neural networks can automatically learn to identify imaging biomarkers that are predictive of Alzheimer's disease, and leverage them to achieve accurate early detection of the disease. 
    more » « less